Partnership with ABC
A Diversified Therapeutics and Diagnostics Platform
Ascendant Biotech Corporation is a biotechnology company and a medical access platform focused on expediting the launch of necessary global medical therapeutics and diagnostics into the market. We have dedicated 2018 and 2019 to identifying and pursuing ground-breaking technologies for terminal and chronic diseases, all the while building relationships that will facilitate our nonclinical and clinical trials.
For the institutions and companies that ABC chooses to partner with, we offer a valuable strategic hedge by creating an additional path to commercialization. ABC concurrently enters a different geographical market for the partnering institution, such that the institution does not divert valuable capital and management bandwidth from its efforts to enter its primary market. This allows for expeditious launch of the institution’s technology into the global market, which then allows for seamless entrance into its primary markets, and thus an acceleration in increasing the institution’s valuation and, therefore, attainment of its primary end goal — to sustainably grow the company, or to exit.